ImmunoCellular Therapeutics Ltd
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey. Show More...
-
Website https://www.eompharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.11 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2008-12 2009-12 2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 TTM Earnings Per Share USD -9.6 -7.6 -17.2 -8.4 -14.0 -6.4 -6.26 -5.87 -7.89 -1.23 1.55 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 1.0 1.0 2.0 3.0 14.0 34.0 Book Value Per Share * USD 4.21 6.28 17.92 17.5 14.74 11.64 3.38 -0.010 0.08 Free Cash Flow Per Share * USD -8.89 -8.75 -11.86 -7.1 -7.24 -7.72 -8.86 -2.37 Return on Assets % -74.64 -114.16 -241.09 -91.4 -84.84 -31.45 -34.66 -46.29 -94.04 -147.97 -209.11 Financial Leverage (Average) 1.06 1.34 2.3 2.21 1.17 1.09 1.08 1.39 2.75 1.51 1.12 Return on Equity % -77.09 -130.1 -480.23 -205.46 -110.23 -35.53 -37.69 -56.83 -158.59 -328.04 Return on Invested Capital % -80.03 -131.19 -480.46 -205.62 -107.27 -35.6 -37.49 -56.33 -149.35 -311.75 Interest Coverage -35.48 -148.6 -94.52 -15.84 -15.21 Current Ratio 16.55 3.8 11.94 3.83 24.52 20.26 18.96 10.82 4.14 2.97 9.53 Quick Ratio 16.41 3.75 11.89 3.78 23.87 19.72 18.01 9.96 3.53 2.81 8.31 Debt/Equity